Indications and Purposes
| 1 Indications And Usage Lucentis Is Indicated For The Treatment Of Patients With: Lucentis, A Vascular Endothelial Growth Factor (Vegf) Inhibitor, Is Indicated For The Treatment Of Patients With: Neovascular (Wet) Age-Related Macular Degeneration (Amd) ( 1.1 ) Macular Edema Following Retinal Vein Occlusion (Rvo) ( 1.2 ) Diabetic Macular Edema (Dme) ( 1.3 ) Diabetic Retinopathy (Dr) ( 1.4 ) Myopic Choroidal Neovascularization (Mcnv) ( 1.5 ) 1.1 Neovascular (Wet) Age-Related Macular Degeneration (Amd) 1.2 Macular Edema Following Retinal Vein Occlusion (Rvo) 1.3 Diabetic Macular Edema (Dme) 1.4 Diabetic Retinopathy (Dr) 1.5 Myopic Choroidal Neovascularization (Mcnv) |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Ranibizumab |